» Articles » PMID: 39313906

Bioelectronic Medicines-A Novel Approach of Therapeutics in Current Epoch

Overview
Journal Curr Pharm Des
Date 2024 Sep 24
PMID 39313906
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bioelectronic medicines aim to diagnose and treat a wide range of illnesses and ailments, including cancer, rheumatoid arthritis, inflammatory bowel disease, obesity, diabetes, asthma, paralysis, blindness, bleeding, ischemia, organ transplantation, cardiovascular disease, and neurodegenerative diseases. The focus of bioelectronic medicine is on electrical signaling of the nervous system. Understanding the nervous system's regulatory roles and developing technologies that record, activate, or inhibit neural signaling to influence particular biological pathways.

Objective: Bioelectronic medicine is an emerging therapeutic option with the interconnection between molecular medicine, neuroscience, and bioengineering. The creation of nerve stimulating devices that communicate with both the central and peripheral nervous systems has the potential to completely transform how we treat disorders. Although early clinical applications have been largely effective across entire nerves, the ultimate goal is to create implantable, miniature closed-loop systems that can precisely identify and modulate individual nerve fibers to treat a wide range of disorders.

Methodology: The data bases such as PubMed, and Clinicaltrial.gov.in were searched for scientific research, review and clinical trials on bioelectronic medicine.

Conclusion: The field of bioelectronic medicine is trending at present. In recent years, researchers have extended the field's applications, undertaken promising clinical trials, and begun delivering therapies to patients, thus creating the groundwork for significant future advancements. Countries and organizations must collaborate across industries and regions to establish an atmosphere and guidelines that foster the advancement of the field and the fulfillment of its prospective advantages.

References
1.
Joseph S, Costanzo M . A novel therapeutic approach for central sleep apnea: Phrenic nerve stimulation by the remedē® System. Int J Cardiol. 2016; 206 Suppl:S28-34. DOI: 10.1016/j.ijcard.2016.02.121. View

2.
Zannad F, De Ferrari G, Tuinenburg A, Wright D, Brugada J, Butter C . Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial. Eur Heart J. 2014; 36(7):425-33. PMC: 4328197. DOI: 10.1093/eurheartj/ehu345. View

3.
Hara S, Kim B, Kuo J, Lee C, Meng E, Pikov V . Long-term stability of intracortical recordings using perforated and arrayed Parylene sheath electrodes. J Neural Eng. 2016; 13(6):066020. DOI: 10.1088/1741-2560/13/6/066020. View

4.
Yi W, Chen C, Feng Z, Xu Y, Zhou C, Masurkar N . A flexible and implantable microelectrode arrays using high-temperature grown vertical carbon nanotubes and a biocompatible polymer substrate. Nanotechnology. 2015; 26(12):125301. DOI: 10.1088/0957-4484/26/12/125301. View

5.
Sahni V, Kessler J . Stem cell therapies for spinal cord injury. Nat Rev Neurol. 2010; 6(7):363-72. PMC: 3755897. DOI: 10.1038/nrneurol.2010.73. View